173 related articles for article (PubMed ID: 34048666)
1. Potential therapeutic value of melatonin in diabetic nephropathy: improvement beyond anti-oxidative stress.
Guo C; He J; Deng X; Wang D; Yuan G
Arch Physiol Biochem; 2023 Dec; 129(6):1250-1261. PubMed ID: 34048666
[TBL] [Abstract][Full Text] [Related]
2. Melatonin alleviates renal injury by activating mitophagy in diabetic nephropathy.
Tang H; Yang M; Liu Y; Zhu X; Liu S; Liu H; Sun L; Song P
Front Endocrinol (Lausanne); 2022; 13():889729. PubMed ID: 35992101
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress in diabetic nephropathy.
Kashihara N; Haruna Y; Kondeti VK; Kanwar YS
Curr Med Chem; 2010; 17(34):4256-69. PubMed ID: 20939814
[TBL] [Abstract][Full Text] [Related]
4. A new prospective on the role of melatonin in diabetes and its complications.
Mok JX; Ooi JH; Ng KY; Koh RY; Chye SM
Horm Mol Biol Clin Investig; 2019 Nov; 40(1):. PubMed ID: 31693492
[TBL] [Abstract][Full Text] [Related]
5. Diabetic Nephropathy: Significance of Determining Oxidative Stress and Opportunities for Antioxidant Therapies.
Darenskaya M; Kolesnikov S; Semenova N; Kolesnikova L
Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569752
[TBL] [Abstract][Full Text] [Related]
6. Sirt1 resists advanced glycation end products-induced expressions of fibronectin and TGF-β1 by activating the Nrf2/ARE pathway in glomerular mesangial cells.
Huang K; Huang J; Xie X; Wang S; Chen C; Shen X; Liu P; Huang H
Free Radic Biol Med; 2013 Dec; 65():528-540. PubMed ID: 23891678
[TBL] [Abstract][Full Text] [Related]
7. The Role of Oxidative Stress in Diabetic Neuropathy: Generation of Free Radical Species in the Glycation Reaction and Gene Polymorphisms Encoding Antioxidant Enzymes to Genetic Susceptibility to Diabetic Neuropathy in Population of Type I Diabetic Patients.
Babizhayev MA; Strokov IA; Nosikov VV; Savel'yeva EL; Sitnikov VF; Yegorov YE; Lankin VZ
Cell Biochem Biophys; 2015 Apr; 71(3):1425-43. PubMed ID: 25427889
[TBL] [Abstract][Full Text] [Related]
8. A Perspective on the Impact of Advanced Glycation End Products in the Progression of Diabetic Nephropathy.
Khanam A; Ahmad S; Husain A
Curr Protein Pept Sci; 2023; 24(1):2-6. PubMed ID: 36366848
[TBL] [Abstract][Full Text] [Related]
9. Melatonin protects podocytes from angiotensin II-induced injury in an in vitro diabetic nephropathy model.
Ji ZZ; Xu YC
Mol Med Rep; 2016 Jul; 14(1):920-6. PubMed ID: 27220903
[TBL] [Abstract][Full Text] [Related]
10. Diabetic nephropathy: where hemodynamics meets metabolism.
Forbes JM; Fukami K; Cooper ME
Exp Clin Endocrinol Diabetes; 2007 Feb; 115(2):69-84. PubMed ID: 17318765
[TBL] [Abstract][Full Text] [Related]
11. [Molecular mechanism of diabetic nephropathy].
Ohshiro Y; Takasu N
Nihon Rinsho; 2006 May; 64(5):997-1003. PubMed ID: 16689387
[TBL] [Abstract][Full Text] [Related]
12. Advanced Oxidation Protein Products Aggravate Tubulointerstitial Fibrosis Through Protein Kinase C-Dependent Mitochondrial Injury in Early Diabetic Nephropathy.
Li X; Xu L; Hou X; Geng J; Tian J; Liu X; Bai X
Antioxid Redox Signal; 2019 Mar; 30(9):1162-1185. PubMed ID: 29482336
[TBL] [Abstract][Full Text] [Related]
13. Melatonin and taurine reduce early glomerulopathy in diabetic rats.
Ha H; Yu MR; Kim KH
Free Radic Biol Med; 1999 Apr; 26(7-8):944-50. PubMed ID: 10232838
[TBL] [Abstract][Full Text] [Related]
14. Positive interaction of mangiferin with selected oral hypoglycemic drugs: a therapeutic strategy to alleviate diabetic nephropathy in experimental rats.
Sekar V; Mani S; Malarvizhi R; Barathidasan R; Vasanthi HR
Mol Biol Rep; 2020 Jun; 47(6):4465-4475. PubMed ID: 32451927
[TBL] [Abstract][Full Text] [Related]
15. Renal Protective Effects of Melatonin in Animal Models of Diabetes Mellitus-Related Kidney Damage: A Systematic Review and Meta-Analysis.
Luo Q; Cai Y; Zhao Q; Jiang Y; Tian L; Liu Y; Liu WJ
J Diabetes Res; 2022; 2022():3770417. PubMed ID: 35746917
[TBL] [Abstract][Full Text] [Related]
16. Amelioration of streptozotocin-induced diabetic nephropathy by melatonin, quercetin, and resveratrol in rats.
Elbe H; Vardi N; Esrefoglu M; Ates B; Yologlu S; Taskapan C
Hum Exp Toxicol; 2015 Jan; 34(1):100-13. PubMed ID: 24812155
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of vanillin on diabetic nephropathy by decreasing advanced glycation end products in rats.
Zabad IEM; Amin MN; El-Shishtawy MM
Life Sci; 2019 Dec; 239():117088. PubMed ID: 31759039
[TBL] [Abstract][Full Text] [Related]
18. Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38MAPK/Akt pathways, compared to α-lipoic acid.
Mao ZM; Shen SM; Wan YG; Sun W; Chen HL; Huang MM; Yang JJ; Wu W; Tang HT; Tang RM
J Ethnopharmacol; 2015 Sep; 173():256-65. PubMed ID: 26226437
[TBL] [Abstract][Full Text] [Related]
19. Novel therapeutic targets for diabetic nephropathy.
Fukami K; Yamagishi S; Ueda S; Okuda S
Endocr Metab Immune Disord Drug Targets; 2007 Jun; 7(2):83-92. PubMed ID: 17584148
[TBL] [Abstract][Full Text] [Related]
20. Vaccination against type 1 angiotensin receptor prevents streptozotocin-induced diabetic nephropathy.
Ding D; Du Y; Qiu Z; Yan S; Chen F; Wang M; Yang S; Zhou Y; Hu X; Deng Y; Wang S; Wang L; Zhang H; Wu H; Yu X; Zhou Z; Liao Y; Chen X
J Mol Med (Berl); 2016 Feb; 94(2):207-18. PubMed ID: 26407577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
